Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips

키워드

참고문헌 (31)

1. Schacht V, "Basics of immunohistochemistry", J Invest Dermatol, 135, pp.e30~ (2015)
2. O’Hurley G, "Garbage in, garbage out: a critical evaluation of strategies used for validation of immunohistochemical biomarkers", Mol Oncol, 8, pp.783~798 (2014)
3. Gustavson MD, "Standardization of HER2 immunohistochemistry in breast cancer by automated quan-titative analysis", Arch Pathol Lab Med, 133, pp.1413~1419 (2009)
4. Kumar V, "Robbins and Cotran pathologic basis of disease" (2005), Elsevier Saunders
5. Pekmezci M, "The Effect of cold ischemia time and", or formalin fixation on estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2results in breast carcinoma, 2012, pp.2012, 947041~
6. Wolff AC, "American Society of Clinical Oncology", College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2testing in breast cancer, 2007, pp.131, 18~43
7. Cross SS, "Does delay in fixation affect the number of mitotic figures in processed tissue?", J Clin Pathol, 43, pp.597~599 (1990)
8. Engel KB, "Effects of preanalytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue", Arch Pathol Lab Med, 135, pp.537~543 (2011)
9. Grizzle WE, "Special symposium: fixation and tissue processing models", Biotech Histochem, 84, pp.185~193 (2009)
10. Wester K, "Paraffin section storage and immunohistochemistry: effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigen", Appl Immunohistochem Mol Morphol, 8, pp.61~70 (2000)
11. Prioleau J, "p53 antigen loss in stored paraffin slides", N Engl J Med, 332, pp.1521~1522 (1995)
12. Xie R, "Factors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections", J Histochem Cytochem, 59, pp.356~365 (2011)
13. Fox CH, "Formaldehyde fixation", J Histochem Cytochem, 33, pp.845~853 (1985)
14. Shi SR, "Standardization of immunohistochemistry for formalin-fixed, paraffin-embedded tissue sections based on the antigen-retrieval technique: from experiments to hypothesis", J Histochem Cytochem, 55, pp.105~109 (2007)
15. Vogt RF Jr, "Quantitative differences among various proteins as blocking agents for ELISA microtiter plates", J Immunol Methods, 101, pp.43~50 (1987)
16. Radulescu RT, "Blocking endogenous peroxidases: a cautionary note for immunohistochemistry", J Cell Mol Med, 11, pp.1419~ (2007)
17. Garba MT, "Alkaline phosphatase inhibition by levamisole prevents 1,25-dihydroxyvitamin D3-stimulated bone mineralization in the mouse", Calcif Tissue, 38, pp.296~302 (1986)
18. Taylor CR, "Quantification of immunohistochemistry:issues concerning methods, utility and semiquantitative assessment II", Histopathology, 49, pp.411~424 (2006)
19. Skliris GP, "Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas", Breast Cancer Res Treat, 118, pp.443~453 (2009)
20. Mazumdar M, "Categorizing a prognostic variable:review of methods, code for easy implementation and applications to decision-making about cancer treatments", Stat Med, 19, pp.113~132 (2000)
21. Hou L, "Tyramine-based enzymatic conjugate repeats for ultrasensitive immunoassay accompanying tyramine signal amplification with enzymatic biocatalytic precipitation", Anal Chem, 86, pp.8352~8358 (2014)
22. Stefanovic´ D, "Romanowsky-Giemsa as a counterstain for immunohistochemistry: optimizing a traditional reagent", Biotech Histochem, 88, pp.329~335 (2013)
23. Dabbs DJ, "Diagnostic immunohistochemistry: theranostic and genomic applications" (2014), Elsevier Saunders
24. Tzankov A, "Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cutoff scores", Leuk Lymphoma, 51, pp.199~212 (2010)
25. Shackelford C, "Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies", Toxicol Pathol, 30, pp.93~96 (2002)
26. Thoolen B, "Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system", Toxicol Pathol, 38(7 suppl), pp.5S~81S (2010)
27. Hanley JA, "Receiver operating characteristic (ROC) methodology:the state of the art", Crit Rev Diagn Imaging, 29, pp.307~335 (1989)
28. Lusted LB, "Signal detectability and medical decision-making", Science, 171, pp.1217~1219 (1971)
29. Søreide K, "Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research", J Clin Pathol, 62, pp.1~5 (2009)
30. Zlobec I, "Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer", J Clin Pathol, 60, pp.1112~1116 (2007)
31. Yaziji H, "Diagnostic Immunohistochemistry: what can go wrong?", Adv Anat Pathol, 13, pp.238~246 (2006)

관련 논문AI추천